The arterial input function is crucial in pharmacokinetic analysis of dynamic contrast-enhanced MRI data. Among other artifacts in arterial input function quantification, the blood inflow effect and nonideal radiofrequency spoiling can induce large measurement errors with subsequent reduction of acc
Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: Fundamental concepts and simulations
✍ Scribed by Cheng Yang; Gregory S. Karczmar; Milica Medved; Walter M. Stadler
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 331 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In dynamic contrast‐enhanced MRI (DCE‐MRI) studies, an accurate knowledge of the arterial contrast agent concentration as a function of time is crucial for the estimation of kinetic parameters. In this work, a novel method for estimating the arterial input function (AIF) based on the contrast agent concentration‐vs.‐time curves in two different reference tissues is described. It is assumed that the AIFs of the two tissues have the same shape, and that simple models with two or more compartments, and unknown kinetic parameters, can describe their tracer concentration‐vs.‐time curves. Based on the principle of self‐consistency, one can relate the two tracer concentration‐vs.‐time curves to estimate their common underlining AIF, together with the kinetic parameters of the two tissues. In practice, the measured concentration‐vs.‐time curves have noise, and the AIFs of the two tissues are not exactly the same due to different dispersion effects. These factors will produce errors in the AIF estimate. Simulation studies show that despite the two error sources, the double‐reference‐tissue method provides reliable estimates of the AIF. Magn Reson Med 52:1110–1117, 2004. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Gd-DTPA kinetics in arterial blood was investigated by dynamic MRI in 47 patients with malignant and benign mammary tumors. Signal enhancement was monitored for 10 min after the beginning of a 1-min infusion of 0.1 mmol/kg Gd-DTPA. Kinetics in blood was biexponential with median half-lives of 21 sec